TABLE 3.
Downregulation of antibiotic targets in biofilms treated with peptide 1018a
Gene | Mean ± SD fold change | Function | Biological role |
---|---|---|---|
gyrA | −4.74 ± 2.2 | DNA gyrase subunit A | DNA replication |
gyrB | −5.00 ± 0.45 | DNA gyrase subunit B | DNA replication |
pbpG | −4.53 ± 2 | d-Alanyl-d-alanine endopeptidase | Cell wall |
ftsI | −2.63 ± 1.0 | Penicillin-binding protein 3 | Cell wall |
pelB | −4.83 ± 0.43 | Biofilm matrix protein | Exopolysaccharide synthesis |
nirS | −4.5 ± 2 | Nitrite reductase precursor | Denitrification |
Results of qRT-PCR performed on RNA extracted from flow cell biofilms. We evaluated the dysregulation of genes involved in antibiotic resistance: gyrA and gyrB are known targets of ciprofloxacin, pbpG and ftsI are involved in ceftazidime and imipenem resistance, and pelB is involved in tobramycin resistance. The gene nirS is involved in biofilm formation. We determined the fold decrease in gene expression by mature biofilms treated with 0.8 μg/ml of peptide 1018 for 24 h compared to the level of expression by untreated mature biofilms.